Trials / Unknown
UnknownNCT04859634
Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging
Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging: A Prospective Multicenter Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This prospective multicenter study will evaluate the efficacy of a real-time artificial intelligence system for detecting multiple ocular fundus lesions by ultra-widefield fundus imaging in real-world settings.
Detailed description
The ocular fundus can show signs of both ocular diseases (e.g., lattice degeneration, retinal detachment and glaucoma) and systemic diseases (e.g., hypertension, diabetes and leukemia). The routine fundus examination is conducive for early detection of these diseases. However, manual conducting fundus examination needs an experienced retina ophthalmologist, and is time-consuming and labor-intensive, which is difficult for its routine implementation on large scale. This study will develop an artificial intelligence system integrating with ultra-widefield fundus imaging to automatically screen for multiple ocular fundus lesions in real time and evaluate its performance in different real-world settings. The efficacy of the system will compare to the final diagnoses of each participant made by experienced ophthalmologists.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Taking an ultra-widefield fundus image | The participant only needs to take an ultra-widefield fundus image as usual. |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2022-02-01
- Completion
- 2022-12-25
- First posted
- 2021-04-26
- Last updated
- 2021-04-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04859634. Inclusion in this directory is not an endorsement.